Sign in to view content

GATHER2 Phase 3 Efficacy Results and GATHER2 Phase 3 Safety Results

Jeffrey S. Heier, MD
Arshad M. Khanani, MD, MA, FASRS

Video
Published 2022

Related

Dry AMD Symposium 1
Annual Meeting Talks
2020
6-Month Results of a Phase 1b-2 Prospective Multicenter Clinical Trial of a Novel Targeted Therapy (AU-011) for the Treatment of Choroidal Melanoma
Amy C. Schefler, MD FACS FASRS
Annual Meeting Talks
2018
Treat-and-Extend Versus Bimonthly Dosing With Aflibercept for the Treatment of Diabetic Macular Edema, 1-Year Outcomes (EVADE Study)
Dilsher S. Dhoot, MD
Annual Meeting Talks
2018

Category: AMD-Non-Neovascular

See more